Freenome is a private biotech company focused on developing blood tests to detect cancer early and make screening accessible for everyone. Backed by a16z, GV and CRV.
About the role
Timing is everything! If you are passionate about Freenome's mission and want to contribute in a meaningful way, we encourage you to submit your CV or resume.
More about this role
Timing is everything! If you are passionate about Freenome's mission and want to contribute in a meaningful way, we encourage you to submit your CV or resume.
Freenome is on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent diseases.
By applying advanced machine learning techniques to recent breakthroughs in genomic science, Freenome is developing simple blood tests to detect early-stage cancer and make treatments more effective. The company has raised $238 million from investors such as RA Capital, Polaris Partners, Perceptive Advisors, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences (formerly Google Life Sciences).
Freenome is building technology to gain an understanding of the body through several analytes derived from blood. These signals include cell-free DNA, methylation of cell-free DNA, cell-free RNA, circulating proteins, and immune profiling derived from thousands of prospective samples. By developing...
Browse similar: Startup jobs